28th Annual Cardiovascular Interventions is organized by Promedica International CME and would be held during Nov 7 - 10, 2017 at Hilton La Jolla Torrey Pines, La Jolla, California, United States Of America.
The target audience for this medical event for interventional cardiologists, cardiac surgeons, vascular surgeons, internists, nurses, cath lab technicians, perfusionists, and those with a special interest in interventional cardiology. No experience in interventional cardiology is required, however a basic understanding of the field is recommended. This CME Conference has been approved with a maximum of 23 AMA PRA Category 1 Credits.
Course descreption :
Cardiologists are trained during their fellowship years in the latest techniques, technologies, standards of practice and guidelines for patient care. However, the practice of medicine changes rapidly and the discipline of interventional cardiology changes dramatically each year. Changes in interventional cardiology directly impact patient care and require constant updates to physician knowledge and practices. Physicians rely on journal articles, interaction with colleagues and lectures throughout the year to keep their knowledge up to date. The primary purpose of the “28th Annual Cardiovascular Interventions” symposium will be to provide the practicing physician and cardiovascular care team with a concentrated exposure to new developments in interventional cardiology that will positively influence patient outcomes.
The 2017 scientific program will be carefully designed by consulting recent key clinical trial data, articles in peer-reviewed scientific journals, physician focus groups, and needs assessments. By attending this program, participants will learn the latest advances and debates in interventional cardiology. They will return to their practice environment armed with the latest evidence-based, practical information to improve patient care and outcomes.
Conference Highlights
• Plenary talks from nationally recognized experts
• Live satellite case transmissions from La Jolla and New York
• Ample question and answer time with course faculty
• Receptions and networking opportunities among colleagues
• Expanded satellite symposia and pre-conference seminar.
Educational Objectives are :
After attending this activity, participants should be able to:
• Apply new technical approaches to specific lesion subsets such as bifurcation lesions, left main lesions, chronic total occlusions and saphenous vein graft disease
• Integrate the latest guidelines and practice improvements into the management of
myocardial function
• Discuss new techniques under development for percutaneous cardiac valve repair and replacement
• Reduce common catheterization laboratory patient complications using new techniques and technologies
• Critique the latest evidence supporting new cardiac imaging modalities such as IVUS and FFR guided stent deployment
• Prescribe the appropriate antithrombotic therapies based on the latest data and guidelines
• Evaluate the indications, practical implantation techniques and evidence base for bioresorbable scaffolds.